Preimplantation Genetic Testing Market Research Report - Global Forecast till 2027

Global Preimplantation Genetic Testing Market Research Report: Information by Procedure (Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening), Type (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, LA Typing and others), Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late-Onset Genetic Disorders, Inherited Genetic Disease and others), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Product and Service (Reagents and Consumables, Instruments, Software and Services) - Global Forecast till 2027

ID: MRFR/HC/6649-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario


The global preimplantation genetic testing market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 375.8 million in 2018 and is projected to register a CAGR of around 10.2% over the forecast period.


Preimplantation genetic testing is a wide term, which is used to describe the genetic analysis of cells of an embryo, and the outcome is used for analysis and guide, which embryos should transfer to the uterus.


Also, nowadays, preimplantation genetic testing has become much more common in North America and Europe due to innovation in genetic technology like NGS and FISH over the traditional genetic technology


Population suffering from disorders related to the gene is expected to drive the preimplantation genetic testing market. Thus, awareness of people about genetic disorders helps to avoid the risk of having babies with certain genetic disorders.


March of Dimes, a voluntary health group of the US stated about 60%,34% and 6% of babies with serious birth defects were born in developing countries, middle-income countries and rich countries respectively.


Additionally,3.3 million children less than five years die each year from serious birth defects worldwide. But genetic medical services and effective interventions, especially in developing countries, could reduce disability and mortality by up to 70%.


Hence raising awareness of preimplantation genetic testing drive the global preimplantation genetic testing market.


Segmentation


The global preimplantation genetic testing market is segmented based on procedure, type, application, technology, product and service, end user, and region.


The global market for preimplantation genetic testing, by procedure, is segmented into preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS). By type, it is divided into chromosomal abnormalities, X-linked diseases, embryo testing, aneuploidy screening, LA typing, and others. By Application it is segmented into embryo HLA typing for stem cell therapy prognosis, late-onset genetic disorders, inherited the genetic disease and others. By technology, the market is divided into


next-generation sequencing, polymerase chain reaction, fluorescence in situ hybridization, comparative genomic hybridization, and single-nucleotide polymorphism. By product and service, it is divided into reagents and consumables, instruments and software and services and lastly by end user the market is divided into maternity centers & fertility clinics, hospitals, diagnostic labs and research laboratories & academic institutes


Preimplantation genetic diagnosis (PGD) segment is expected to hold the largest market share of the preimplantation genetic testing market owing to rising awareness patients as well as healthcare professionals about genetic testing. Also, preimplantation genetic screening (PGS) segment is anticipated profitable growth during the forecast period as it reduces the miscarriage risk, increase the possibility of a healthy pregnancy in all age groups


By technology, the next-generation sequencing segment also expected to hold a large share as its cost is reduced and its capability to detect mosaicism.


By product & service, the reagents and consumables segment expected to hold the largest market share as there is continuous declination infertility of female due to the increase in maternity age.


In the current scope of the study, the segments mentioned above are covered into four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.


The preimplantation genetic testing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European preimplantation genetic testing market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Preimplantation Genetic Testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Preimplantation Genetic Testing market in the Middle East and Africa has been segmented into the Middle East and Africa.


Key Players



  • Natera, Inc.

  • CooperSurgical, Inc.

  • Hoffmann-La Roche AG

  • Illumina, Inc.

  • IGENOMIX

  • Reprogenetics, LLC

  • Genea Limited

  • PerkinElmer, Inc.

  • Genesis Genetics Ltd.

  • Quest Diagnostics Incorporated

  • Thermo Fisher Scientific, Inc

  • Bioarrayn Genetics

  • Laboratory Corporation of America Holdings

  • California Pacific Medical Center

  • Reproductive Health Science Ltd


Regional Market Summary


Global Preimplantation Genetic Testing Market Share (%), by Region, 2017  Preimplantation Genetic Testing Market


Sources: MRFR Analysis


March of Dimes, the US voluntary health group stated that 7.9 million children are born with a serious birth defect of genetic or partially genetic origin, that is, 6% of total births in a year worldwide. This estimation is drawn from a study of 193 countries. As the genetic defects are growing, there is an increase in awareness about preimplantation genetic testing in population worldwide.


US Department of Health & Human Services stated that Infertility is very common. Thus, out of 100 couples in the US, about 12 to 13 of them have trouble getting pregnant. About 10 in 100 (6.1 million) women in the US aged 15 to 44 have a problem in getting pregnant or staying pregnant. Hence the prevalence of infertility causes an increase in the number of IVF procedures in the US, which is expected to drive the market. 


As the maternal age in Europe is increasing complications regarding childbirth along with the threat of abnormalities in chromosomes is also rising. This leads to an increase in preimplantation genetic testing for baby birth with normal genes.


The rising participation of market players is also strongly impacting the growth of the Asia-Pacific Preimplantation Genetic Testing market.


On the other hand, the Middle East and Africa held the least share in the global preimplantation genetic testing market due to the low economic development, especially within the African region.


Market Segmentation 


Global Preimplantation Genetic Testing Market, by Procedure



  • Preimplantation Genetic Diagnosis (PGD)

  • Preimplantation Genetic Screening (PGS) Beta Thalassemia


Global Preimplantation Genetic Testing Market, by Type



  • Chromosomal Abnormalities

  • X-linked Diseases

  • Embryo Testing

  • Aneuploidy Screening

  • HLA Typing

  • Others


Preimplantation Genetic Testing Market, by Application



  • Embryo HLA typing for stem cell therapy

  • IVF Prognosis

  • Late-Onset Genetic Disorders

  • Inherited Genetic Disease

  • Others


Preimplantation Genetic Testing Market, by Technology



  • Next-Generation Sequencing

  • Polymerase Chain Reaction

  • Fluorescence in Situ Hybridization

  • Comparative Genomic Hybridization

  • Single-Nucleotide Polymorphism


Preimplantation Genetic Testing Market, by Product and Service



  • Reagents and Consumables

  • Instruments

  • Software and Services


Global Preimplantation Genetic Testing Market, by End User



  • Maternity Centers & Fertility Clinics

  • Hospitals, Diagnostic Labs

  • Research Laboratories & Academic Institutes


Global Preimplantation Genetic Testing Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Pharmaceutical companies

  • Government and private laboratories

  • Research and development (R&D) companies

  • Research laboratories

  • Market research and consulting service providers



Report Scope:
Report Attribute/Metric Details
  Market Size   2025: Significant Value
  CAGR   10.2% (2019-2025)
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Procedure, Type, Application, Technology, Product and Service
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Natera, Inc.CooperSurgical, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., IGENOMIX, Reprogenetics, LLC, Genea Limited, PerkinElmer, Inc., Genesis Genetics Ltd., Quest Diagnostics Incorporated, Thermo FisherScientific, Inc, Bioarrayn Genetics, Laboratory Corporation of America Holdings, California Pacific Medical Center and Reproductive Health Science Ltd
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers   Rising awareness regarding its benefits


Frequently Asked Questions (FAQ) :


The preimplantation genetic testing market would register a CAGR of 10.2% during the forecast period of 2019 to 2025.

The preimplantation genetic testing market valuation in 2018 was USD 375.8 million.

Rising awareness regarding its benefits would increase the preimplantation genetic testing market volume.

The Preimplantation genetic diagnosis (PGD) segment would lead to the preimplantation genetic testing market.

The next-generation sequencing has the upper hand in the preimplantation genetic testing market.

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunities

5.4 Pricing Analysis

Chapter 6. Global Preimplantation Genetic Testing Market, by Procedure

6.1 Introduction

6.2 Preimplantation Genetic Diagnosis (PGD)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Preimplantation Genetic Screening (PGS)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Preimplantation Genetic Testing Market, by Type

7.1 Introduction

7.2 Chromosomal Abnormalities

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 X-linked Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Embryo Testing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Aneuploidy Screening

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 HLA Typing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Preimplantation Genetic Testing Market, by Application

8.1 Introduction

8.2 Embryo HLA typing for stem cell therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 IVF Prognosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Late-Onset Genetic Disorders

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Inherited Genetic Disease

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Preimplantation Genetic Testing Market, by Technology

8.1 Introduction

8.2 Next-Generation Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Polymerase Chain Reaction

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Fluorescence in Situ Hybridization

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Comparative Genomic Hybridization

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Single-Nucleotide Polymorphism

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Preimplantation Genetic Testing Market, by Product and Service

8.1 Introduction

8.2 Reagents and Consumables

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Instruments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Software and Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Preimplantation Genetic Testing Market, by End User

9.1 Introduction

9.2 Maternity Centers & Fertility Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Hospitals and Diagnostic Labs

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Research Laboratories & Academic Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Preimplantation Genetic Testing Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Natera, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 CooperSurgical, Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 F. Hoffmann-La Roche AG

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Illumina, Inc.

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 IGENOMIX

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Reprogenetics, LLC

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Genea Limited

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 PerkinElmer, Inc.

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Genesis Genetics Ltd.

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Quest Diagnostics Incorporated

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Thermo Fisher Scientific, Inc

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.12 Bioarrayn Genetics

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.13 Laboratory Corporation of America Holdings

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.14 California Pacific Medical Center

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.15 Reproductive Health Science Ltd

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.16 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Global Preimplantation Genetic Testing Market

Chapter 13 Appendix

LIST OF TABLES

Table 1 Preimplantation Genetic Testing Market Synopsis, 2020-2027

Table 2 Preimplantation Genetic Testing Market Estimates and Forecast, 2020-2027(US Million)

Table 3 Global Preimplantation Genetic Testing Market, by Region, 2020-2027(USD Million)

Table 4 Global Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 5 Global Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 6 Global Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 7 Global Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 8 Global Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 9 Global Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 10 North America: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(US Million)

Table 11 North America: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 12 North America: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 13 North America: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 14 North America: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 15 North America: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 16 US: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 17 US: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 18 US: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 19 US: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 20 US: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 21 US: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 22 Canada: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 23 Canada: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 24 Canada Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 25 Canada Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 26 Canada Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 27 Canada: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 28 South America: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 29 South America: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 30 South America: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 31 South America: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 32 South America: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 33 South America: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 34 Europe: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 35 Europe: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 36 Europe Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 37 Europe Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Million)

Table 38 Europe Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 39 Europe: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 40 Western Europe: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 41 Western Europe: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 42 Western Europe: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 43 Western Europe: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 44 Western Europe: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 45 Western Europe: Preimplantation Genetic Testing Market, by End User, 2020-2027(USD Million)

Table 46 Eastern Europe: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 47 Eastern Europe: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 48 Eastern Europe Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 49 Eastern Europe Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 50 Eastern Europe Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 51 Eastern Europe: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 52 Asia-Pacific: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 53 Asia-Pacific: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 54 Asia-Pacific: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 55 Asia-Pacific: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 56 Asia-Pacific: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 57 Asia-Pacific: Preimplantation Genetic Testing Market, End User, 2020-2027(USD Million)

Table 58 Middle East & Africa: Preimplantation Genetic Testing Market, by Procedure, 2020-2027(USD Million)

Table 59 Middle East & Africa: Preimplantation Genetic Testing Market, by Type, 2020-2027(USD Million)

Table 60 Middle East & Africa: Preimplantation Genetic Testing Market, by Application, 2020-2027(USD Million)

Table 61 Middle East & Africa: Preimplantation Genetic Testing Market, by Technology, 2020-2027(USD Million)

Table 62 Middle East & Africa: Preimplantation Genetic Testing Market, by Product and Service, 2020-2027(USD Million)

Table 63 Middle East & Africa: Preimplantation Genetic Testing Market, End User, 2020-2027(UD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Preimplantation Genetic Testing Market

Figure 3 Market Dynamics for Global Preimplantation Genetic Testing Market

Figure 4 Preimplantation Genetic Testing Market Share, by Type, 2020

Figure 5 Preimplantation Genetic Testing Market Share, by Treatment, 2020

Figure 6 Preimplantation Genetic Testing Market Share, End User, 2020

Figure 7 Preimplantation Genetic Testing Market Share, by Region, 2020

Figure 8 North America: Preimplantation Genetic Testing Market Share, by Country, 2020

Figure 9 Europe: Preimplantation Genetic Testing Market Share, by Country, 2020

Figure 10 Asia-Pacific: Preimplantation Genetic Testing Market Share, by Country, 2020

Figure 11 Middle East & Africa: Preimplantation Genetic Testing Market Share, by Region, 2020

Figure 12 Preimplantation Genetic Testing Market: Company Share Analysis, 2020 (%)

Figure 13 Natera, Inc.: Key Financials

Figure 14 Natera, Inc.: Segmental Revenue

Figure 15 Natera, Inc.: Geographical Revenue

Figure 16 CooperSurgical, Inc.: Key Financials

Figure 17 CooperSurgical, Inc.: Segmental Revenue

Figure 18 CooperSurgical, Inc.: Geographical Revenue

Figure 19 F. Hoffmann-La Roche AG: Key Financials

Figure 20 F. Hoffmann-La Roche AG: Segmental Revenue

Figure 21 F. Hoffmann-La Roche AG: Geographical Revenue

Figure 22 Illumina, Inc.: Key Financials

Figure 23 Illumina, Inc.: Segmental Revenue

Figure 24 Illumina, Inc.: Geographical Revenue

Figure 25 IGENOMIX: Key Financials

Figure 26 IGENOMIX: Segmental Revenue

Figure 27 IGENOMIX: Geographical Revenue

Figure 28 Reprogenetics, LLC: Key Financials

Figure 29 Reprogenetics, LLC: Segmental Revenue

Figure 30 Reprogenetics, LLC: Geographical Revenue

Figure 31 Genea Limited: Key Financials

Figure 32 Genea Limited: Segmental Revenue

Figure 33 Genea Limited: Geographical Revenue

Figure 34 PerkinElmer, Inc.: Key Financials

Figure 35 PerkinElmer, Inc.: Segmental Revenue

Figure 36 PerkinElmer, Inc.: Geographical Revenue

Figure 37 Genesis Genetics Ltd.: Key Financials

Figure 38 Genesis Genetics Ltd.: Segmental Revenue

Figure 39 Genesis Genetics Ltd.: Geographical Revenue

Figure 40 Quest Diagnostics Incorporated: Key Financials

Figure 41 Quest Diagnostics Incorporated: Segmental Revenue

Figure 42 Quest Diagnostics Incorporated: Geographical Revenue

Figure 43 Thermo Fisher Scientific, Inc: Key Financials

Figure 44 Thermo Fisher Scientific, Inc: Segmental Revenue

Figure 45 Thermo Fisher Scientific, Inc: Geographical Revenue

Figure 46 Bioarrayn Genetics: Key Financials

Figure 47 Bioarrayn Genetics: Segmental Revenue

Figure 48 Bioarrayn Genetics: Geographical Revenue

Figure 49 Laboratory Corporation of America Holdings: Key Financials

Figure 50 Laboratory Corporation of America Holdings: Segmental Revenue

Figure 51 Laboratory Corporation of America Holdings: Geographical Revenue

Figure 52 California Pacific Medical Center: Key Financials

Figure 53 California Pacific Medical Center: Segmental Revenue

Figure 54 California Pacific Medical Center: Geographical Revenue

Figure 55 Reproductive Health Science Ltd: Key Financials

Figure 56 Reproductive Health Science Ltd: Segmental Revenue

Figure 57 Reproductive Health Science Ltd: Geographical Revenue




This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.